TMS Center of Colorado First in Denver Area to Offer New FDA-Cleared Treatment for Obsessive-Compulsive Disorder (OCD) in Adults
DENVER –TMS Center of Colorado is the first in the region and one of the first in the nation to offer a new non-drug treatment for obsessive-compulsive disorder (OCD) in adults using the Brainsway Deep Transcranial Magnetic Stimulation System (Deep TMS®). OCD is the second FDA indication granted for Brainsway Deep TMS, which was cleared in 2013 for the treatment of major depressive disorder (MDD). Read More >>
TMS Center of Colorado is pleased to announce that we are the first in Denver—and among the first in the United States—to offer deep TMS treatment of obsessive-compulsive disorder (OCD) in adults. Read More >>
BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatment of Obsessive-Compulsive Disorder
BrainsWay Ltd. (TASE: BRIN), the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain disorders, today announced completion of the first shipment of its Deep TMS system for the treatment of OCD in adults.
Read More >>
Psychotherapy is one of the few careers where you find far more females than males. Approximately 80 percent of marriage and family therapists are women. They are core mental health professionals — 4 in 10 Americans have sought the help of a therapist, according to research by the Barna Group.
Read More >>
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD). Read More >>
Charlene Campbell slipped a blue cap over her ponytail, velcroed a chinstrap into place and popped in her mouthguard. As she settled into her seat at the Hampton Veterans Affairs Medical Center’s Behavioral Health Center, Dr. Kenneth Miller guided a plastic helmet-like device, lined on the inside with coils, over her head. “On the count of three, I’m going to go ahead and get you started,” Miller, a psychiatrist, said. “Ready?”
Read More >>
Did you know up to 2.5million people worldwide have multiple sclerosis: yet a cure remains elusive? Research, however, has never been more fruitful, with breakthroughs coming thick and fast. In the past few months alone, we’ve seen significant strides in our understanding of this condition.
Read More >>
A new method of brain stimulation designed by Stanford researchers to treat depression rapidly improved depressive symptoms in a small group of treatment-resistant patients who had suffered for decades with no relief, according to a study published in Brain.
This new method of high-dose transcranial magnetic stimulation uses rapid, repeated bursts of magnetic pulses to stimulate the brain.
Read More >>
Nicole Aldridge of Hampton tried drug after drug to treat her depression. Two years later, she was still searching for answers…
Read More >>
Depression afflicts 16 million Americans. One third don’t get better with treatment. A surprising new drug may change that…
Read More >>
Welcome to the second issue of 2017 of the Magnet. I am pleased to say the first issue of this year, which is available only in an electronic format, was clicked open by more than sixty per cent of the CTMSS membership. Read More >>
Repetitive transcranial magnetic stimulation (rTMS) significantly reduced phantom limb pain in patients who had lost limbs to land mine explosions for up to 15 days, according to a study in the Journal of Pain (2016 ;17:911-918). Sixty-three percent of patients experienced a greater than 50% reduction in pain. No significant side effects were reported. Read More >>
Ted Wirecki, M.D. appointed editor of the Clinical TMS Society Newsletter
Ted Wirecki, M.D. is pleased to accept the appointment as editor of the quarterly Clinical TMS Society Newsletter. Dr. Wirecki has recently completed a six year term on the Executive Committee of the Board of the Society and continues to serve as a Board member. The society has over 300 members who practice TMS in the United States and internationally including most of the leading researchers and academics in the field.
October, 2016 – Dr. OZ
Check out this video of Dr. OZ explaining TMS Therapy.
August, 2016 – Brainsway
Deep Transcranial Magnetic Stimulation (Deep TMS) using Brainsway’s H-coils is a novel development in non-invasive neuromodulation. The unique ability to stimulate deeper neuronal structures than any other commercially available TMS system may seem almost mythical; but Deep TMS is a reality, born of ingenuity, science and engineering. Brainsway holds the exclusive rights to the Deep TMS technology, which was originally patented by the NIH, with subsequent patents by Brainsway. The Deep TMS H-coils feature a complex coil geometry designed to effectively enhance the depth penetration of TMS… Read More >>
August, 2016 – Brainsway
Potential for a safe breakthrough methodology of direct medication transfer to the brain for treating brain tumors & other critical conditions
The prestigious Journal of Neuroscience recently published a paper on Brainsway’s Deep TMS methodology used for controlled opening of the blood-brain barrier.
The blood-brain barrier is the interface between the central nervous system and the blood system that nourishes it. The barrier regulates the transfer of molecules between the blood and the brain, maintaining a constant environment surrounding the nerve cells to ensure their normal functionality… Read More >>
June, 2016 – Current Psychiatry
The utility of TMS for treating depression continues to widen, as the technology is refined.
Since 2008, the FDA has cleared 4 transcranial magnetic stimulation (TMS) devices for treating depression. In that time, the availability of TMS has steadily grown within and outside the United States… Read More >>
May, 2016 – TMS Center of Colorado
Based on data presented at the May meeting of the Clinical TMS Society and the American Psychiatric Association in Atlanta it is becoming clear that leading researchers are now thinking of brain functioning as organized along the lines of neural networks rather than discrete structures. These networks may also be referred to as neural brain circuits. The normal functioning of these networks is mediated by complex neurochemical and electrophysiological processes… Read More>>
April, 2016 – NBC Affiliate KMIR
Check out the video here, and see how this non-invasive therapy “is getting results”.
April 21, 2016 – NPR
As someone with autism spectrum disorder, John Elder Robison knows what it’s like to feel emotionally removed from situations. Robison tells Fresh Air’s Terry Gross that throughout his life people have told him, “There’s this emotional language you’re missing. There are stories in people’s eyes. There are messages.”… Read More >>
The Clinical TMS Society Consensus Review and Treatment Recommendations for
TMS Therapy for Major Depressive Disorder.
March, 2016 – Brain Stimulation
Prefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated daily over 4–6 weeks (20–30 sessions) is US Food and Drug Administration (FDA) approved for treating Major Depressive Disorder in adults who have not responded to prior antidepressant medications… Read More >>
February 29, 2016 – Brainsway.com
Results demonstrate a substantial therapeutic advantage for deep and widespread stimulation using Brainsway’s proprietary ADHD coil over superficial stimulation with a standard figure-8 coil
Brainsway® Ltd. (TASE: BRIN), a leader in non-invasive brain stimulation, is pleased to announce final results from a phase II clinical study investigating the efficacy of Deep transcranial magnetic stimulation (Deep TMS) using a specialized electromagnetic coil developed for the treatment of attention deficit hyperactivity disorder (ADHD) in adults. The study was conducted at the Soroka University Medical Center in Beer Sheva, Israel, in collaboration with the Ben Gurion University, and was led by Principal Investigators Dr. Hadar Shalev and Prof. Abraham Zangen… Read More >>
Brainsway Partners With U.S. Navy to Provide Innovative Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression Treatment
October 2015 – CNN Money
Brainsway (TASE:BRIN), the leader in the development of advanced noninvasive treatments for brain disorders, today announced its partnership with the United States Navy to implement Deep Transcranial Magnetic Stimulation (Deep TMS). The devices purchased by the Navy will be used to help treat sailors suffering from clinical depression… Read More >>
August 2015 – Deleware Online, The News Journal
Bam. Bam. Bam. Bam. Sitting in an outpatient room at the Comprehensive Spine Center in Dover Wednesday while wearing an oversized helmet, that’s what Tony McKinney hears and feels sporadically on his head over the course of a 20 minute treatment… Read More >>
May 2015 – Clinical TMS Society–A White Paper
Transcranial Magnetic Therapy (TMS) is currently indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. In order to promote… Read More >>
August 2014 – Silicon Angle
In the wake of Robin William’s tragic suicide following years of suffering from depression, the spotlight has fallen on ways to treat the illness and prevent future deaths. The focus has always been on medicine or therapy, but recently a number of technologies… Read More >>
June 2014 – Wall ST Daily
Depression is one of the most misunderstood and debilitating mental conditions. The symptoms range from mild to severe – with potentially dangerous effects on sufferers… Read More >>
June 2014 – Medscape
Repetitive high-dose transcranial magnetic stimulation (rTMS) is safe and rapidly decreases suicidal thoughts, new research suggests. A randomized study of 41 inpatients in suicidal crisis showed that those who received high-dose rTMS to the left prefrontal cortex… Read More >>
April 2009 – Los Angeles Times
On an antidepressant and still depressed? Techniques new and old may help. The landmark STAR*D study, published in the November 2006 issue of the American Journal of Psychiatry, demonstrated that depression is more likely to yield – and less likely to recur – when a patient is treated with both an antidepressant and cognitive therapy… Read More >>
June 2009 – U.S. News & World Report – Health
In 25 or 50 or 75 years, maybe today’s scourges—cancer, heart disease, diabetes—will have receded into medical lore as 21st-century versions of childbirth fever (it once killed a quarter of the women who delivered at some hospitals) or tuberculosis… Read More >>
December 2009 – CNN
London, England (CNN) – No one doubts that the most high-profile health crisis of 2009 was the unexpected outbreak of H1N1 – the swine flu virus that has claimed almost 10,000 lives, according to the World Health Organization… Read More >>
November 2008 – The Washington Post
Steve Newman had suffered from major depression from the time he was 13. He tried innumerable treatments: psychotherapy and medications. Approaching 60, single by necessity and friendless by choice, he decided his train had only two stops left before suicide… Read More >>
October 2008 – U.S. News & World Report – Health
The NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy system has been approved by the U.S. Food and Drug Administration for people with major depressive disorder who haven’t seen satisfactory improvement from at least one prior antidepressant medication… Read More >>
October 2008 – The Wall Street Journal
You sit in what looks like a dentist’s chair and a psychiatrist places a metal coil against your head. Rapid magnetic pulses penetrate your scalp and skull and produce a mild electrical current in the left prefrontal cortex of your brain… Read More >>
rTMS is a recently introduced method capable of altering cortical excitability beyond the time of stimulation. It has been employed in several psychiatric disorders with variable degrees of efficacy… Read More >>